Complementary, holistic, and integrative medicine: St. John's wort

Pediatrics in Review

Volumn 28, Issue 2, 2007, Pages 69-72

  Charrois, Theresa L ^a   Sadler, Candace ^a   Vohra, Sunita ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIDEPRESSANT AGENT; CALENDULA FLORES EXTRACT; CARBAMAZEPINE; CYCLOSPORIN; GARLIC EXTRACT; HYPERICUM PERFORATUM EXTRACT; ORAL CONTRACEPTIVE AGENT; PLACEBO; PLANT EXTRACT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; VERBASCUM THAPSUS EXTRACT; WARFARIN;

ALTERNATIVE MEDICINE; APPETITE; BREAST FEEDING; CALENDULA FLORES; CHILL; CLINICAL TRIAL; COLIC; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DIARRHEA; DISEASE EXACERBATION; DIZZINESS; DROWSINESS; DRUG DOSAGE FORM; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERICUM PERFORATUM; INTEGRATIVE MEDICINE; LABORATORY TEST; LACTATION; LETHARGY; MAJOR DEPRESSION; MANIA; MEDICINAL PLANT; NERVOUSNESS; NEUROPATHY; OTALGIA; OTITIS MEDIA; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; REVIEW; SEROTONIN SYNDROME; SIDE EFFECT; SKIN ALLERGY; SYSTEMATIC REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VERBASCUM PERFORATUM; VITAL SIGN; WEIGHT CHANGE; XEROSTOMIA;

ADOLESCENT; BREAST FEEDING; CHILD; CHILD, PRESCHOOL; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; DRUG INTERACTIONS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPERICUM; INFANT; INFANT, NEWBORN; PEDIATRICS; PHYTOTHERAPY; PLANT PREPARATIONS; PREGNANCY; TREATMENT OUTCOME;

EID: 33947688097     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.28-2-69     Document Type: Review

References (24)

1. Natural medicines monograph. Hypericum perforum. Natural Medicines Comprehensive Database 2006. Available at: www.naturaldatabase.com
2. Ernst E. The risk-benefit profile of commonly used herbal therapies: gingko, St. John's wort, ginseng, Echinacea, saw palmetto and kava. Ann Intern Med. 2002;136:42-53
3. Linde K, Berner M, Egger M, Mulrow C. St. John's wort for depression: meta-analysis of randomized controlled trials. Br J Psychiatry. 2005;186:99-107
4. Kobak KA, Taylor LV, Warner G, Futterer R. St. John's wort versus placebo in social phobia: results from a placebo-controlled pilot study. J Clin Psychopharmacol. 2005;25:51-58
5. Kobak KA, Taylor LV, Bystritsky A, et al. St. John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study. Int Clin Psychopharmacol. 2005;20:299-304
6. Martinez B, Kasper S, Ruhrmann S, Moller HJ. Hypericum in the treatment of seasonal affective disorders. J Geriatr Psychiatry Neurol. 2004;7:S29-S33
7. Hicks SM, Walker AF, Gallagher J, Middleton RW, Wright J. The significance of "nonsignificance" in randomized controlled studies: a discussion inspired by a double-blinded study on St. John's wort (Hypericum perforatum L) for premenstrual symptoms. J Altern Complement Med. 2004;10:925-932
8. Cala S, Crismon ML, Baumgartner J. A survey of herbal use in children with attention-deficit-hyperactivity disorder or depression. Pharmacotherapy. 2003;23:222-307
9. Redvers A, Kanagaratnam G. How many patients self-medicate with St John's wort? Psychiatr Bull. 2001;25:254-256
10. Findling RL, McNamara NK, O'Riordan MA, et al. An openlabel pilot study of St. John's wort in juvenile depression. J Am Acad Child Adolesc Psychiatry. 2003;42:908-914
11. Simeon J, Nixon MK, Milin R, Jovanovic R, Walker S. Openlabel pilot study of St. John's wort in adolescent depression. J Clin Adolesc Psychopharmacol. 2005;15:293-301
12. Hubner WD, Kirste T. Experience with St. John's wort (Hypericum perforatum) in children under 12 years with symptoms of depression and psychovegetative disturbances. Phytother Res. 2001;15:367-370
13. Sarrell EM, Mandelberg A, Cohen HA. Efficacy of naturopathic extracts in the management of ear pain associated with acute otitis media. Arch Pediatr Adolesc Med. 2001;155:796-799
14. Hammerness P, Basch E, Ulbricht C, et al. St. John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics. 2003;44:271-282
15. Briggs GG, Freeman RK, Yaffee SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 7th ed. London, Great Britain: Lippincott Williams & Wilkins; 2005
16. Grush LR, Nierenberg A, Keefe B, Cohen LS. St. John's wort during pregnancy. JAMA. 1998;280:1566
17. Klier CM, Schmid-Siegel B, Schafer MR, et al. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants. J Clin Psychiatry. 2006;67:305-309
18. Lee A, Minhas R, Matsuda N, Lam H, Ito S. The safety of St. John's wort (Hypericum perforatum) during breastfeeding. J Clin Psychiatry. 2003;64:966-968
19. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001;61:2163-2175
20. Mills E, Wu P, Johnston BC, Gallicano K, Clarke M, Guyatt G. Natural health product-drug interactions: a systematic review of clinical trials. Ther Drug Monit. 2005;27:549-557
21. Murphy PA. St. John's wort and oral contraceptives: reasons for concern? J Midwifery Womens Health. 2002;47:447-450
22. Wurglics M, Schubert-Zsilavecz M. Hypericum perforatum: a "modern" herbal antidepressant: pharmacokinetics of active ingredients. Clin Pharmacokinet. 2006;45:449-468
23. Shah AK, Avery BA, Wyandt CM. Content analysis and stability evaluation of selected commercial preparations of St. John's wort. Drug Dev Ind Pharm. 2005;31:907-916
24. Markowitz JS, Donovan JL, DeVane CL, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA. 2003;290:1500-1504